Menu
Back to Journals » Lung Cancer: Targets and Therapy » Volume 8
Review
Spotlight on brigatinib and its potential in the treatment of patients with metastatic ALK-positive non-small cell lung cancer who are resistant or intolerant to crizotinib
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 11,642 | Dovepress* | 8,283+ | 1,329 | 9,612 | |
| PubMed Central* | 3,359 | 476 | 3,835 | ||
| Totals | 11,642 | 1,805 | 13,447 | ||
| *Since 13 October 2017 | |||||
| Total mentioned | Delicious | Others | |||
|---|---|---|---|---|---|
| 5 | 1 | 0 | 0 | 0 | 4 |
View citations on PubMed Central and Google Scholar